Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 25, 2017
Which patents cover Metoprolol Tartrate, and when can generic versions of Metoprolol Tartrate launch?
Metoprolol Tartrate is a drug marketed by Mylan, Gland Pharma Ltd, Luitpold, Sagent Strides, Watson Labs, Hospira, Teva Pharms, Aurobindo Pharma, Teva, Sun Pharm Inds Inc, Fresenius Kabi Usa, Claris, Mutual Pharm, Prinston Inc, Sun Pharm Inds, Apothecon, Ipca Labs Ltd, Sandoz Inc, Hikma Farmaceutica, Alembic Pharms Ltd, Purepac Pharm, Rubicon Res Pvt Ltd, Sandoz, and West-ward Pharms Int. and is included in thirty-five NDAs.| Patents: | 0 |
| Applicants: | 24 |
| NDAs: | 35 |
| Suppliers / Packagers: see list | 63 |
| Clinical Trials: see list | 286 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | METOPROLOL TARTRATE at DailyMed |
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 076670-001 | Jan 15, 2004 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Apothecon | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 074258-002 | Jan 27, 1994 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Rubicon Res Pvt Ltd | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 200981-003 | Oct 28, 2014 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Alembic Pharms Ltd | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 202870-003 | Nov 6, 2013 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Purepac Pharm | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 074380-001 | Jul 29, 1994 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,135 others who get our Drug Patent Expiration Alerts:
